Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
We are seeking a Senior Director, R&D Quality (GCP–GLP–GvP) is a key leader within Crescent’s Quality organization, responsible for providing strategic and hands-on Quality Assurance leadership for clinical, nonclinical, and pharmacovigilance activities across Crescent’s development programs. You partner closely with Clinical Development, Clinical Operations, Nonclinical Development, Pharmacovigilance, Regulatory, and external partners to ensure phase-appropriate compliance with global GxP regulations, robust data integrity, and continuous inspection readiness within a highly outsourced development model.
Please note, this person must be local to the Waltham, MA office.